ArticleLangmuir : the ACS journal of surfaces and colloids2026
Profiling High-Abundance Serum Proteins in the Corona of Nanodiamonds Using Mass Spectrometry.
Article in Langmuir : the ACS journal of surfaces and colloids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanodiamonds (NDs) are promising agents for various biomedical applications. Upon entering the body, NDs interact with proteins to form a "protein corona" (PC), which influences their biological fate and cytotoxicity. In this study, 100 nm NDs were incubated with human serum, and MALDI-TOF MS was used to identify the major proteins dominating the corona on oxidized detonation ND (oxDND) and high-pressure high-temperature ND (HPHT ND). The results show that PC formation depends on serum protein abundance, protein affinity, kinetics, and ND properties. At a serum protein concentration of 5.3 μg/mL, both NDs are predominantly coated with apolipoprotein A1 (APO A1; Mw = 28,000 Da). As serum protein concentration decreased to 1.6 μg/mL, oxDND becomes dominated by human serum albumin (HSA; Mw = 66,500 Da), while HPHT ND exhibits a mixed APO A1-HSA corona. Differences in pore structure also influence protein binding: the larger pores of oxDND (9.41 nm) allow access to larger proteins like HSA, whereas smaller HPHT ND pores (3.39 nm) favor low molecular weight (Mw) proteins. Hemolysis assays indicated good hemocompatibility for both NDs, while cell viability assays revealed higher cytotoxicity for HPHT ND with a mixed corona compared to oxDND with an HSA-dominant corona. These findings highlight the importance of profiling high-abundance proteins in ND coronas and demonstrate how protein binding preferences modulate ND cytotoxicity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.